Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Essential Drugs Monitor No. 032 (2003)
(2003; 48 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentEDITORIAL - 25 years of essential medicines progress
View the documentANNIVERSARY ISSUE - Improving drug regulation
View the documentDrug pricing survey in KwaZulu-Natal
View the documentReducing costs through regional pooled procurement
View the documentDispensing prescribers - a threat to appropriate medicines use?
View the documentDrug and therapeutics committees: vehicles for improving rational drug use
View the documentAnnouncing ICIUM 2004
View the documentAccess to essential medicines: a global necessity
View the documentMemories of the First Expert Committee Meeting and celebrating 25 years later
View the document25 years of essential medicines: events around the world
View the documentPersonal reflections on 25 years of the WHO Model List of Essential Medicines
View the documentDrug utilization in Latin America - the example of DURG-LA
View the documentGlobal TB Drug Facility: improving access to TB drugs
View the documentDemystifying antiretroviral therapy in resource-poor settings
View the documentCBIA: improving the quality of self-medication through mothers’ active learning
View the documentIndian hospital drug use study shows need to improve prescribing
View the documentWHO’s new Model Formulary - promoting consumer rights and patient safety

Essential Drugs Monitor No. 032 (2003)


Essential Drugs Monitor

The Essential Drugs Monitor is produced and distributed by the WHO Department of Essential Drugs and Medicines Policy (EDM). It is published in Chinese, English, French, Spanish and Russian, and has a global readership of some 300,000 to whom it is free of charge. The Monitor carries news of developments in national drug policies, therapeutic guidelines, current pharmaceutical issues, educational strategies and operational research.

WHO’s Department of Essential Drugs and Medicines Policy seeks to ensure that all people - wherever they may be - are able to obtain the drugs they need at a price that they and their country can afford; that these drugs are safe, effective and of good quality; and that they are prescribed and used rationally.

All correspondence should be addressed to:

The Editor
Essential Drugs Monitor
World Health Organization
CH-1211 Geneva 27, Switzerland
Fax: +41 22-791-4167
e-mail: medmail@who.int


to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017